BioSyent Statistics
Total Valuation
BioSyent has a market cap or net worth of 95.31 million. The enterprise value is 83.61 million.
| Market Cap | 95.31M |
| Enterprise Value | 83.61M |
Important Dates
The next estimated earnings date is Friday, November 15, 2024.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | Sep 4, 2024 |
Share Statistics
| Shares Outstanding | n/a |
| Shares Change (YoY) | -3.48% |
| Shares Change (QoQ) | -0.64% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 8.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.37, with an EV/FCF ratio of 46.49.
| EV / Earnings | 16.00 |
| EV / Sales | 3.44 |
| EV / EBITDA | 13.37 |
| EV / EBIT | 13.96 |
| EV / FCF | 46.49 |
Financial Position
The company has a current ratio of 6.13, with a Debt / Equity ratio of 0.03.
| Current Ratio | 6.13 |
| Quick Ratio | 4.72 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.46 |
| Interest Coverage | 130.27 |
Financial Efficiency
Return on equity (ROE) is 20.88% and return on invested capital (ROIC) is 14.68%.
| Return on Equity (ROE) | 20.88% |
| Return on Assets (ROA) | 12.86% |
| Return on Capital (ROIC) | 14.68% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.84 |
| Inventory Turnover | 1.34 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +41.07% in the last 52 weeks. The beta is 0.93, so BioSyent's price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | +41.07% |
| 50-Day Moving Average | 7.92 |
| 200-Day Moving Average | 7.00 |
| Relative Strength Index (RSI) | 58.98 |
| Average Volume (20 Days) | 1,768 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioSyent had revenue of 24.71 million and earned 5.22 million in profits. Earnings per share was 0.44.
| Revenue | 24.71M |
| Gross Profit | 19.71M |
| Operating Income | 6.09M |
| Pretax Income | 6.92M |
| Net Income | 5.22M |
| EBITDA | 6.26M |
| EBIT | 6.09M |
| Earnings Per Share (EPS) | 0.44 |
Balance Sheet
The company has 12.72 million in cash and 825,934 in debt, giving a net cash position of 11.89 million.
| Cash & Cash Equivalents | 12.72M |
| Total Debt | 825,934 |
| Net Cash | 11.89M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 25.88M |
| Book Value Per Share | 2.23 |
| Working Capital | 18.41M |
Cash Flow
In the last 12 months, operating cash flow was 1.85 million and capital expenditures -48,765, giving a free cash flow of 1.80 million.
| Operating Cash Flow | 1.85M |
| Capital Expenditures | -48,765 |
| Free Cash Flow | 1.80M |
| FCF Per Share | n/a |
Margins
Gross margin is 79.77%, with operating and profit margins of 24.63% and 21.14%.
| Gross Margin | 79.77% |
| Operating Margin | 24.63% |
| Pretax Margin | 28.01% |
| Profit Margin | 21.14% |
| EBITDA Margin | 25.34% |
| EBIT Margin | 24.63% |
| FCF Margin | 7.28% |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 1.62%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 1.62% |
| Dividend Growth (YoY) | 9.22% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 27.84% |
| Buyback Yield | 3.48% |
| Shareholder Yield | 5.10% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BioSyent has an Altman Z-Score of 12.96.
| Altman Z-Score | 12.96 |
| Piotroski F-Score | n/a |